News
Media
Academy
Conferences
Publications
CME/CE
Job Board
Subscribe
Directories

Spotlight -

Concierge Medicine Forum|

|Videos|October 1, 2021

Introduction: Optimizing Patient Management in Hypothyroidism

Author(s)Todd Frieze, MD, FACP, FACE

Todd Frieze, MD, FACP, FACE, introduces himself as well as the purpose of today’s presentation, which is to optimize patient management in hypothyroidism.

Episodes in this series

EP. 1 Introduction: Optimizing Patient Management in Hypothyroidism

EP. 1 Introduction: Optimizing Patient Management in Hypothyroidism

EP. 2 Overview of Hypothyroidism

EP. 2 Overview of Hypothyroidism

EP. 3 Clinical Manifestations, Implications and Diagnosis of Hypothyroidism

EP. 3 Clinical Manifestations, Implications and Diagnosis of Hypothyroidism

EP. 4 Hypothyroidism: Goals, Challenges, and Special Populations

EP. 4 Hypothyroidism: Goals, Challenges, and Special Populations

EP. 5 Patient Case: Hypothyroidism Diagnosis and Optimal Management

EP. 5 Patient Case: Hypothyroidism Diagnosis and Optimal Management

EP. 6 Hypothyroidism: Challenges in Optimal Patient Management

EP. 6 Hypothyroidism: Challenges in Optimal Patient Management

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

‘Physician associate’ title gains momentum across state legislatures

Key trends in health care technology

$100,000 H-1B visa fee would hit rural and high-poverty counties hardest, study finds

Physicians who use AI face a ‘competence penalty,’ Johns Hopkins study finds

GE HealthCare reports Q3 revenue growth, raises earnings guidance amid tariff headwinds

© 2025 MJH Life Sciences^®

All rights reserved.